FDA clears allograft, autograft use in Xtant Medical’s Irix-C cervical cage: 5 highlights

Belgrade, Mont.-based Xtant Medical earned FDA clearance to use autografts and/or allografts in its Irix-C cervical cage.

Advertisement

Here are five highlights:

 

1. The clearance also expanded the range of allowable levels from C3-T1 to C2-T1.

 

2. Before this clearance, the Irix-C cervical cage was only usable with autogenous bone graft.

 

3. Xtant’s 3Denim and patented OsteoSponge, both allografts, will work with Irix-C.

 

4. OsteoVive, a cellular allograft, may also be used with Irix-C.

 

5. The Irix-C Cervical Integrated Fusion System is a standalone cervical intervertebral fusion device designed for degenerative disc disease treatment.

 

More articles on devices:
Filling a biologic void — Pinnacle Spine’s CEO Zach Sowell on the pioneering bone graft technology
FDA approves full-body MRI for St. Jude Medical’s Proclaim Elite SCS System: 5 key points
1st cases performed with Xtant Medical’s Xspan Laminoplasty Fixation System: 5 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.